Globus Medical, Inc.
GMED
$91.70
-$2.10-2.24%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 140.59M | 118.97M | 202.85M | 75.46M | 26.51M |
| Total Depreciation and Amortization | 68.82M | 71.21M | 70.68M | 66.14M | 67.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.68M | 57.78M | -139.03M | 26.10M | 89.52M |
| Change in Net Operating Assets | -21.51M | 1.74M | -56.63M | 9.60M | 27.27M |
| Cash from Operations | 248.59M | 249.70M | 77.87M | 177.30M | 210.34M |
| Capital Expenditure | -46.20M | -35.82M | -46.56M | -36.10M | -17.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -252.55M | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -65.25M | -40.03M | 0.00 | 167.49M | -87.01M |
| Cash from Investing | -111.45M | -75.84M | -299.11M | 131.39M | -104.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -449.99M | -- |
| Issuance of Common Stock | 62.76M | 11.08M | 4.70M | 11.22M | 69.28M |
| Repurchase of Common Stock | -45.21M | -39.75M | -25.66M | -192.74M | -934.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.33M | -3.38M | -3.97M | -3.89M | -8.62M |
| Cash from Financing | 13.22M | -32.04M | -24.94M | -635.40M | 59.73M |
| Foreign Exchange rate Adjustments | 4.03M | 512.00K | 14.36M | 3.54M | -4.28M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.39M | 142.32M | -231.82M | -323.17M | 161.67M |